首页 | 本学科首页   官方微博 | 高级检索  
     


Understanding Health-Related Quality of Life in Patients with Mantle Cell Lymphoma
Affiliation:1. Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisconsin, 1111 Highland Avenue, Room 4031, Madison, WI 53705, USA;2. Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA;1. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK;2. Department of Haemato-Oncology, St Bartholomew’s Hospital, London, UK;1. Lymphoma Department, MSKCC, 1275 York Avenue, Box 468, New York, NY 10065, USA;2. Department of Medicine, Medical Oncology, New York, NY, USA;3. Department of Medicine, Lymphoma Service, New York, NY, USA;1. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Rosselló, 149-153, Barcelona 08036, Spain;2. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain;3. Hematopathology Unit, Hospital Clínic of Barcelona, University of Barcelona, Villarroel 170, Barcelona 08036, Spain
Abstract:
Keywords:Mantle cell lymphoma  HRQOL  Toxicity  Chronic therapy  Adverse events  Patient-reported outcomes
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号